Europe — EMA

Oxaliplatin Sun

Oxaliplatin, the active ingredient in Oxaliplatin Sun, is a chemotherapy agent presented as a sterile injectable solution for intravenous use.

Oxaliplatin

Request sourcing

Pack/s

What is Oxaliplatin?

Oxaliplatin, the active ingredient in Oxaliplatin Sun, is a chemotherapy agent presented as a sterile injectable solution for intravenous use. It is employed in the treatment of certain cancers, particularly colorectal cancer, and is administered under the supervision of oncology specialists.

GNH USA supplies Oxaliplatin Sun as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres, hospitals and pharmacies worldwide.

What is Oxaliplatin used for?

Oxaliplatin Sun is a platinum‑based chemotherapy drug that interferes with DNA replication in malignant cells. It is indicated for: - Colorectal cancer: Provides the primary treatment in combination with 5‑fluorouracil and leucovorin. - Gastric cancer: Used as part of a multimodal treatment regimen for advanced disease. - Pan‑pan t ?? - t t

What are the side effects of Oxaliplatin?

The most ...

What precautions apply to Oxaliplatin?

The

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →